NAV3 and endometrial cancer: High protein expression in a non-malignant endometrial cell line and the markedly reduced expression in all tested endometrial cancer lines further indicated a potential role of NAV3 as a tumour suppressor in the endometrium and was consistent with TCGA expression data.